Objective Bronchodilators are routinely used in the long-term therapy of patients with COPD.
These drugs are generally evaluated for their short-term bronchodilatory effects. Long-term …

Inhaled ipratropium bromide (IPR) is effective in the management of COPD. The purpose of
this study was to determine if doubling the standard dose of IPR resulted in greater …

This retrospective analysis of data from two multi-center, randomized, double-blind, parallel
group studies compared the efficacy of fluticasone propionate/salmeterol (FSC) 250/50mcg …

Study objectives: To compare the efficacy of adding formoterol or salbutamol to regular
ipratropium bromide treatment in COPD patients whose conditions were suboptimally …

Several studies have suggested that anticholinergics are at least equal to or may be
superior to beta agonists in the treatment of stable COPD. However, since most previous …

Background Combining bronchodilators has been shown to be beneficial in patients with
COPD. The additive effects of short-acting bronchodilators added to maintenance tiotropium …

Study objective To conduct a post hoc pharmacoeconomic evaluation of two double-blind,
randomized, prospective, parallel group studies comparing the long-term efficacy and safety …

The degree of acute improvement in spirometric indices after bronchodilator inhalation
varies among chronic obstructive pulmonary disease (COPD) patients, and depends upon …

Bronchodilators form the foundation of symptomatic treatment of COPD. Several long-acting
bronchodilators are now available for use in COPD, but publications of large-scale studies of …

To evaluate the role of inhaled ipratropium bromide alone vs oral theophylline plus inhaled
β-agonist or the combination of all three in patients with stable COPD, the following double …